Business
Pre Close Statement
Pre Close Statement.
About this update from Synectics Plc
[{"type":"text","content":"\n Synexus Clinical Research PLC\n28 September 2007\n\n\nSynexus Clinical Research plc (\"the Company\")\n\nPre Close Statement\n\nSynexus Clinical Research plc, which provides clinical trials services for the\nglobal pharmaceutical industry, confirms it will release its interim results for\nthe six months ended 30 September 2007 in the week commencing 3 December 2007.\nPrior to entering its close period, the Company today issues a trading update.\n\nAs expected, given previously announced delays to major contracts, trading in\nthe first half has been challenging. However, significant new contract wins\nsince 31 March 2007 mean that the Company's forward order book is presently at a\nrecord level of £18.5m with a further £19.0m of outstanding bid proposals.\n\nThe Directors remain confident about the prospects for the Company for the\nremainder of the financial year.\n\nPress enquiries\n\nSynexus Clinical Research plc Tel: +44 (0)1257 230723\n\nMichael Fort, Chief Executive\n\nPaul McCluskey, Chief Financial Officer\n\nBiddicks - Financial Public Relations Tel: +44 (0)20 7448 1000\n\nZoe Biddick\n\n\nBrewin Dolphin - NOMAD Tel: 0845 213 8600\n\nMark Brady/Alison Barrow\n\n\n\n\n This information is provided by RNS\n The company news service from the London Stock Exchange\n ","length":1324,"tagName":"div"}]